209. Billiga aktier inom biotech

episode

Börslunch not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

ICYMI: Teresa & Melissa Reunite, Whitney Gets Real & Taylor Wants It on Camera 29 min · 28 Sep 2026 · Two Ts In A Pod with Teddi Mellencamp and Tamra Judge

Café com Deus Pai | Vai dar certo 3 min · 28 Sep 2026 · Café Com Deus Pai | Podcast oficial

Sam Morril's Guide to NYC! 1h 5m · 28 Sep 2026 · Are You Garbage? Comedy Podcast

How to Stop Living Paycheck to Paycheck & Finally Get Ahead 1h 8m · 28 Sep 2026 · The Mel Robbins Podcast

Matthew McConaughey & Woody Harrelson 1h 4m · 28 Sep 2026 · Conan O’Brien Needs A Friend

What Is a Covenant? 26 min · 28 Sep 2026 · Renewing Your Mind

Report any issue

Source

Recorded06 May 2022

Publisheranchor.fm ↗

Handlerec:9306450

Show notes

Bioteknik är en sektor som ligger rätt i tiden då efterfrågan på läkemedel förväntas öka när världens befolkning blir allt äldre. Ulrica Slåne Bjerke, förvaltare på Arctic Asset Management, berättar i EFN Marknad om hur du ska tänka om du vill investera i sektorn.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related